C.Q. Pharmaceutical Holding Co., Ltd.

XSEC:000950 Stock Report

Market Cap: CN¥9.6b

C.Q. Pharmaceutical Holding Future Growth

Future criteria checks 3/6

C.Q. Pharmaceutical Holding is forecast to grow earnings and revenue by 29.7% and 10.1% per annum respectively. EPS is expected to grow by 29.2% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

29.7%

Earnings growth rate

29.2%

EPS growth rate

Healthcare earnings growth23.0%
Revenue growth rate10.1%
Future return on equity7.7%
Analyst coverage

Low

Last updated17 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:000950 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026100,5081,009N/A511
12/31/202590,194888N/A1731
12/31/202480,617706N/A5571
9/30/202481,42843057325N/A
6/30/202479,183379422666N/A
3/31/202480,123592208451N/A
12/31/202380,119655264509N/A
9/30/202375,6826901,0091,201N/A
6/30/202375,8691,065-759-536N/A
3/31/202371,5711,006117351N/A
1/1/202367,82995218286N/A
9/30/202266,8331,104-1,196-790N/A
6/30/202265,084969-459-21N/A
3/31/202263,9381,038-841-361N/A
12/31/202162,5211,005-239250N/A
9/30/202161,022954-1,584-1,125N/A
6/30/202158,2661,022-1,122-643N/A
3/31/202152,016880-310112N/A
12/31/202045,220884254632N/A
9/30/202039,096755398868N/A
6/30/202034,70362475589N/A
3/31/202033,599726-932-252N/A
12/31/201933,844788-619202N/A
9/30/201932,536888-2,453-1,674N/A
6/30/201929,897844-2,293-1,656N/A
3/31/201927,641700-2,262-1,786N/A
12/31/201825,803691-2,010-1,706N/A
9/30/201822,021123-2,017-1,900N/A
6/30/201821,501715N/A-1,998N/A
3/31/201821,385613N/A-1,572N/A
12/31/201721,190590N/A-1,102N/A
9/30/201719,1701,723N/A-379N/A
12/31/201620,487956N/A-307N/A
12/31/201519,419394N/A227N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000950's forecast earnings growth (29.7% per year) is above the savings rate (2.8%).

Earnings vs Market: 000950's earnings (29.7% per year) are forecast to grow faster than the CN market (26.2% per year).

High Growth Earnings: 000950's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 000950's revenue (10.1% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 000950's revenue (10.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000950's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y